Literature DB >> 9286559

The UNOS OPTN Waiting List and Donor Registry: 1988-1996.

A M Harper1, J D Rosendale.   

Abstract

1. There were 49,233 registrations on the combined UNOS waiting list as of October 31, 1996, an increase of 207% over December 31, 1988. Of these, 69% were awaiting kidney transplantation, and 14.6% were awaiting liver transplantation. 2. More than one-half of all patients on the UNOS waiting list on October 31, 1996 were blood type O, 60% were White, 58% were male, and 56% were aged 18-49. 3. Annual additions to the UNOS kidney waiting list grew from 11,909 in 1988 to 17,635 in 1995. The largest increase in waiting list size was in the lung waiting list, which grew from 126 additions in 1988 to 1,706 additions in 1995. 4. For patients registering in 1994, median waiting times to transplant were longest for kidney registrants (842 days), followed by heart-lung registrants (612 days). The shortest waiting times for this cohort were experienced by liver registrants (173 days). 5. In general, death rates per 1,000 patient years at risk have declined during 1988-1995. Death rates were higher for patients awaiting life-saving organs (liver, heart, lung, heart-lung) than for non-lifesaving organs (kidney, pancreas, kidney-pancreas). 6. There were 5,359 cadaveric and 3,215 living donors recovered in 1995, a 31% and 76% increase, respectively, over the numbers recovered in 1988. 7. The number of organs recovered per cadaveric donor increased from 2.98 in 1988 to 3.68 in 1995. At the same time, the number of organs transplanted per cadaveric donor recovered increased from 2.73 to 3.24. 8. Large increases were seen in the number of recovered donors who were liver (45-81%), pancreas (14-24%), and lung (3-17%) donors between 1988-1995. 9. The number of cadaveric donors aged 50 or older has increased 172% from 1988 (475 donors) to 1995 (1,292 donors). 10. The typical cadaveric donor in 1995 was a White male with blood type O, between the ages 18-34. In 1995, a typical living donor was a White female with blood type O, aged 35-49. 11. Between 1988-1995, the percentage of minority donation has increased for cadaveric donors (16.4-22.8%), and for living donors (24.0-27.5%). 12. The number of spouses or other unrelated living donors has increased from 4% in 1988 to 11% in 1995.

Entities:  

Mesh:

Year:  1996        PMID: 9286559

Source DB:  PubMed          Journal:  Clin Transpl        ISSN: 0890-9016


  8 in total

Review 1.  A ventricular assist device as a bridge to recovery, decision making, or transplantation in patients with advanced cardiac failure.

Authors:  Siyamek Neragi-Miandoab
Journal:  Surg Today       Date:  2012-07-20       Impact factor: 2.549

2.  Single lung transplantation from a brain-dead donor for a patient with idiopathic pulmonary fibrosis. A breakthrough after new legislation in Japan.

Authors:  S Miyoshi; M Minami; M Ohta; M Okumura; S Takeda; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-06

3.  Systematic review: extracorporeal bio-artificial liver-support system for liver failure.

Authors:  Jinyang Gu; Xiaolei Shi; Haozhen Ren; Qingxiang Xu; Jun Wang; Jiangqiang Xiao; Yitao Ding
Journal:  Hepatol Int       Date:  2012-03-28       Impact factor: 6.047

Review 4.  Gender imbalance in living organ donation.

Authors:  Nikola Biller-Andorno
Journal:  Med Health Care Philos       Date:  2002

Review 5.  Development of hepatic tissue engineering.

Authors:  Henning Cornelius Fiegel; Ulrich Kneser; Dietrich Kluth; Roman Metzger; Holger Till; Udo Rolle
Journal:  Pediatr Surg Int       Date:  2009-06-02       Impact factor: 1.827

6.  Six-year dialysis freedom in end-stage renal disease.

Authors:  Aamir Jalal Al Mosawi
Journal:  Clin Exp Nephrol       Date:  2009-05-30       Impact factor: 2.801

Review 7.  Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory.

Authors:  Henning C Fiegel; Peter M Kaufmann; Helge Bruns; Dietrich Kluth; Raymund E Horch; Joseph P Vacanti; Ulrich Kneser
Journal:  J Cell Mol Med       Date:  2007-11-16       Impact factor: 5.310

8.  Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat.

Authors:  H C Fiegel; G Pryymachuk; S Rath; O Bleiziffer; J P Beier; H Bruns; D Kluth; R Metzger; R E Horch; H Till; U Kneser
Journal:  J Cell Mol Med       Date:  2008-05-24       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.